Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections.

One of the main challenges for tuberculosis (TB) therapy is how to deliver drugs to the site of disease. Once the body’s immune system is infected with tuberculosis, it forms granulomas—tight clusters ...

Chest CT-based radiomic analysis revealed 16 distinct features that could differentiate tumourlets (TLs) from granulomas, with flatness showing a specificity of 100% and long-run high grey-level ...

Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...

See References Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org, for additional references pertaining to this table. An adverse prognosis indicates a ...

Neutrophils induce anti-inflammatory -- or M2 -- macrophages deep in their granulocyte core. The dense globular structures of granulomas in animals, particularly in the lungs, have been studied.

XTMAB-16 is an anti-TNFa monoclonal antibody currently under investigation. Based on its ability to block TNFa, XTMAB-16 may disrupt an inflammatory pathway and help slow granuloma formation. XTMAB16 ...

BASEL, Switzerland & LONDON & NEW YORK--(BUSINESS WIRE)--Roivant (Nasdaq: ROIV) and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and ...